chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On the Night of the day after I received the vaccine, which was about 24hours after, I started noticing a rash that covered all of my upperbody, being most prominent on my torso, chest, and back. The rash also spread to my upper legs, and looked like red splotches. I did not have hives are any large bumps, but the rash did have a little bit of texture, and it was slightly itchy at times.
Bell"s palsy, followed by retractable hiccups, and AFib. Bell's palsy was treated with acyclovir and steroid. Still has symptoms, but beginning to resolve. Hiccups lasted 17 days. Two hospital stays for IV medications to try and stop hiccups and get AFib under control. Will begin physical therapy for Bell's palsy on April 29, 2021.  Hospitalized at facility two times for total of 5 days
Left upper thigh 1.5cm in diameter, erythematous circular area with 0.5cm indurated area in the center.  No vesicles, no other lesions.
Body stiffness so much so I literally could only wiggle my toes. Another side effect was a  red swollen lump in a shape of an oval that a preschool may draw. The area is very tender  to touch  and formed next to injection site a day after and is still present two days after.
Severe throbbing left leg pain that awakened me from sleep and kept me awake for a few hours. Every 1-2 minutes my left leg would experience severe shooting pain and my knee would bend and jolt.
dizziness; vertigo; weakness; vaccination site swell; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), VERTIGO (vertigo), ASTHENIA (weakness) and VACCINATION SITE SWELLING (vaccination site swell) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced DIZZINESS (dizziness), VERTIGO (vertigo), ASTHENIA (weakness) and VACCINATION SITE SWELLING (vaccination site swell). At the time of the report, DIZZINESS (dizziness), VERTIGO (vertigo), ASTHENIA (weakness) and VACCINATION SITE SWELLING (vaccination site swell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
She states it has been past 6 months and she has not received the second vaccine yet.; she developed an "erosive lichens planus"; Dry mouth; Tiredness; Sore arm; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On 6th February 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. On 7th February 2020, 1 days after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced pain in arm and tiredness. On 27th February 2020, the patient experienced erosive lichen planus and dry mouth. On an unknown date, the patient experienced incomplete course of vaccination. On 10th August 2020, the outcome of the erosive lichen planus and dry mouth were not recovered/not resolved. On an unknown date, the outcome of the pain in arm and tiredness were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the pain in arm, erosive lichen planus, dry mouth and tiredness to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported for 1st dose. The age at vaccination was not applicable for 2nd dose. The patient received Shingrix and had a sore arm and tiredness that eventually went away and about 3 weeks after the vaccine, she developed an erosive lichens planus on her lip diagnosed by an oral surgeon and it still was not completely healed.  The patient also reported having a dry mouth as well.  The reporter stated it had been past 6 months and she has not received the second vaccine yet, which led to incomplete course of vaccination. The reporter did not consent to follow up and declined to provide HCP information.
Patient received Moderna Vaccine instead of Pfizer for her second shot. She only reported a sore arm and otherwise is doing fine.
This spontaneous report was received from a physician refers to a patient of unknown demographics. Patient's relevant medical history, concurrent conditions and drug reactions/allergies were unspecified. On 17-JUL-2015 the patient was vaccinated with a dose of an improperly stored VARIVAX (Merck) (strength, dose/frequency, lot # unspecified). Concomitant therapy was unspecified. No adverse experience was reported. Additional information has been requested.
No adverse event; administered expired dose to patient, dose administered after 30 day Use By Date or after manufacturer date of expiry; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered expired dose to patient, dose administered after 30 day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) in a 3-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     It was unknown if patient received any other vaccine in the 4 weeks prior to COVID-19 vaccine.     On 15-Mar-2023, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered expired dose to patient, dose administered after 30 day Use By Date or after manufacturer date of expiry). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered expired dose to patient, dose administered after 30 day Use By Date or after manufacturer date of expiry) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (administered expired dose to patient, dose administered after 30 day Use By Date or after manufacturer date of expiry).    Concomitant drugs were not reported.  It was reported that the individual multi dose monovalent 6 months to 5 years vial of 2. mL size was initially stored in refrigerator on 09-Mar-2023. The vial was not exposed to temperature excursion.  Treatment medications were not provided.  This case is reported for patient 2 of 2.   This case was linked to US-MODERNATX, INC.-MOD-2023-715991 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-715991:Patient 01 (Master case)
Elevated resting heart rate; weakness; dizzy; extreme fatigue; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 11Mar2021 08:15 (Lot number: EN6201) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hashimoto" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: ESTRADIOL; LEVOTHYROXINE; PROGESTERONE; TESTOSTERONE. The following information was reported: HEART RATE INCREASED (non-serious) with onset 12Mar2021 06:00, outcome "recovered with sequelae", described as "Elevated resting heart rate"; ASTHENIA (non-serious) with onset 12Mar2021 06:00, outcome "recovered with sequelae", described as "weakness"; DIZZINESS (non-serious) with onset 12Mar2021 06:00, outcome "recovered with sequelae", described as "dizzy"; FATIGUE (non-serious) with onset 12Mar2021 06:00, outcome "recovered with sequelae", described as "extreme fatigue"; HEADACHE (non-serious) with onset 12Mar2021 06:00, outcome "recovered with sequelae", described as "headache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of heart rate increased, asthenia, dizziness, fatigue, headache.  Additional information: The patient has no known allergies. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient was not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Patient says the pain started right when she received the vaccination and got worse throughout the day. She said she cannot move her arm at all anymore. She is having a difficult time dressing herself or doing anything around the house. The patient says she felt as thought the vaccinator injected too high on her arm. I asked her where exactly she received her dose and she said it was very close to her shoulder, almost directly below the shoulder.
Patient was admitted to a local Hospital  on 1/17/22 for COVID pneumonia. This is considered a breakthrough case.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 17-OCT-2012 14:19, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
aches and pains after 1st Pfizer covid 19 vaccine injection; This is a spontaneous report from a contactable consumer or other non hcp. A 32-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The medical history and concomitant medications were not reported.  On an unspecified date the patient experienced aches and pains after 1st pfizer covid 19 vaccine injection (pain). The outcome of event was unknown.  No follow-up attempts are needed. No further information is expected.
On 02/24 wake up to fever of 101.4 and severe body aches and took day off from work. On next day woke up to nose bleeding with lot of clots coming out of my nose. Only medication i took was OTC ibuprofen that i took month ago as well for fever.
knees stiff; left arm pain; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 13th February 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 13th February 2020, less than a day after receiving Shingrix, the patient experienced pain in arm. On 22nd February 2020, the patient experienced stiff knees. On an unknown date, the outcome of the pain in arm and stiff knees were recovering/resolving.   It was unknown if the reporter considered the pain in arm and stiff knees to be related to Shingrix.  Additional details were provided as follows: The patinet received Shingrix and experienced pain in arm and stiff knees. Reporter consented to follow up.
FLU-LIKE SYMPTOMS; LOSING BODY HAIR ( ARMS AND LEGS); ACHES; CHILLS; FEVER; This spontaneous report received from a patient via a company representative concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On 08-APR-2021, the subject experienced flu-like symptoms. On 08-APR-2021, the subject experienced losing body hair ( arms and legs). On 08-APR-2021, the subject experienced aches. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the flu-like symptoms, fever, aches, chills and losing body hair ( arms and legs) was not reported. This report was non-serious.
Swollen gland under my left arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen gland under my left arm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 025J20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced LYMPHADENOPATHY (Swollen gland under my left arm). At the time of the report, LYMPHADENOPATHY (Swollen gland under my left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: TCR / NNI
Dizzy \ Light headed; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy \ Light headed) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (Dizzy \ Light headed). At the time of the report, DIZZINESS (Dizzy \ Light headed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not provided.  Treatment medication was not provided.
?Covid arm? Red marking about 2 inches wide and 1 inch tall at injection site
Returned home around 4:30 PM from vaccine and felt a bit tired & not hungry for dinner. Iced my arm and took 2 Tylenol as my head began hurting.  I went to bed at 9:00 PM and woke up around 1:00 AM with an excruciating headache and felt nauseous I took 2 more Tylenol, but could not fall back asleep. I felt very nauseous and was unable to go back to sleep. Oddly, I was sitting up wide awake and for a period of about 30 minutes, I began seeing brightly colored images that looked like they were floating in front of me. It was extremely odd as my eyes were open and I was awake. I finally fell back asleep around 5:30 AM and had horrifying vivid nightmares. When I woke up around 8:00 AM my headache was still there and I felt somewhat nauseous but not as bad as during the night.  My headache continued through the day on Saturday and I continued to take Tylenol about every 6 hours. I attempted to go to bed around 9 PM when I experienced horrible chest pain that radiated through my chest and into the left side of my throat. This was frightening because the pain did not let up for 7 to 8 hours, even after taking a Tagamet. I've never suffered from heartburn previously other than when I was 8 months pregnant with twins. I was lucky to have any medication at home and that was only because my husband suffered from heartburn frequently. I finally fell asleep around 6:00 am for just a few hours and woke up feeling tired, but no headache or chest pain. Other than feeling tired, the symptoms appeared to all be gone. On a positive note, my arm never became sore!
This spontaneous case reported by a consumer, describes the occurrence of myalgia (sore arm after the 1st dose) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On May 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On May 27, 2021, patient experienced myalgia (sore arm after the 1st dose). At the time of the report, myalgia (sore arm after the 1st dose) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medication use and treatment information not reported.
Patient is a male who presents for a 1 month history of numbness, tingling and weakness of the fourth and fifth fingers of the left hand. He presents with his wife who concurs with history. He describes the numbness tingling sensation extending up his left hand into the proximal forearm and what would be the ulnar distribution.  He is noted weakness of the fourth and fifth digits such that he cannot fully grasp with that hand compared to his contralateral hand.  Patient describes more numbness and weakness than frank pain although he has noticed it when he is woken up at night.  He has not taken any specific medication for this.  Patient states this started approximately April eighth ninth or 10th several days after getting his first Pfizer vaccination in the left arm.  That was a Pfizer Lot number EN 8737 expiration July 2021 given on April 6 at the urgent care vaccination site.  Patient feels the vaccine was given behind his deltoid on the shoulder rather than mid deltoid muscle.  He did not have any pain numbness or shooting sensations immediately.  Reports the muscle was a little sore that day or the next but really nothing of significance until several days later. He did not report any significant redness or swelling at the site of the vaccination.  He reports not having any photos of the side of the vaccination but he and his wife did take a photo about a week ago of the area of that he feels is still tender in the posterior shoulder region It is not clear to me whether the soreness in the shoulder extended down to the hand and then improve leaving the hand symptoms or whether soreness disappeared at the time the hand arm symptoms came on. He has not had any similar symptoms he denies having any carpal tunnel or hand problems in the past. Past medical history is pertinent for: some chronic back pain in the thoracic or lumbar region that began after traumatic vertebral fractures following a motor vehicle accident in 2012. he is followed by Dr. of pain specialist of, She is maintained on chronic methadone.  He has had recent lower thoracic or lumbar block with plans to have radioablation therapy to those nerve roots in the next several days. Also has well-controlled hypertension on lisinopril 20 mg and takes 81 mg enteric-coated aspirin daily. Here for evaluation as symptoms have not resolved on their own over the last 3 to 4 weeks
The soreness started same evening, by morning I could hardly move left arm.  My bicep muscle was fine; I could "curl" and could therefore work with patients (in CT), but pain level was quite inappropriate for a vaccination. This is day 6 and I can just now raise arm above head. I had much difficulty steering car or taking my scrubs off over my head.  I feel "soreness at site" is a gross misrepresentation. I have several co-workers who can shoot x-rays but can't left x-ray cassette (5-7#) with sore arm or can sit in office but can't deal with tasks at a childs birthday party. I am getting more mobility but pain level is still requiring more Tylenol/Motrin than I've taken in 5 years total.  If I had an active vacation planned, it would be ruined, and I have one 10 days from now.  I hope I can paddle a kayak. The warning about "sore at site" and ratings of mild or moderate problems woefully underestimates the true interferance with daily activities. Pain (no mention of time factor), and 1/100 adults is simply not true.
Information has been received from a physician and registered nurse concerning a 13 year old 140 lb 64 in white female with spinal asymmetry, and no known allergies or birth defects, who on 06-NOV-2007 at 11:00 hours received a second subcutaneous dose in the right arm of varicella virus vaccine live (Oka/Merck) (lot#658423/1180U). Concomitant vaccination included a first dose intramuscularly in the left arm of hepatitis A vaccine (inactive) (MSD) (lot# 659187/1259U). There was no concomitant medication. There was no reported illness at the time of the vaccinations and no adverse events following prior vaccination. It was reported that on 06-NOV-2007, she developed a mild varicella like rash which persisted and progressed into full blown chicken pox. Follow up information from the registered nurse indicated that on the evening of 13-NOV-2007, she developed an itchy rash all over her body. By 15-NOV-2007, it was indicated that she had in excess of approximately 150 spots all over her body, face, and extremities. The itchy feeling was treated with diphenhydramine (BENADRYL). It was indicated that on 17-NOV-2007, therapy was initiated with hydroxyzine (ATARAX) because the itchiness was so bad. It was noted by the reporter that because of the patient's age, the experience was very stressful on her because of body image disturbance. It was indicated that on 19-NOV-2007, she had begun clearing, and was considered to have recovered. There was no laboratory or diagnostic test performed. The mother of the patient mentioned that "chicken pox was going around the patient's school." The patient's vaccination history included on 09-DEC-1995, a first dose of varicella virus vaccine live (Oka/Merck). A product quality complaint was not reported. Additional information is not expected.
Symptoms started on 11/17/16 around 2:00pm by patient experiencing pain in arm. She looked at arm around 8:00pm and seen redness and swelling down on (R) antecubital. Patient in on 11/18/16 at 12:00pm and arm antecubital to 3 inches above and across width of arms red, swollen and tender to touch.
This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) and PRODUCT STORAGE ERROR (Expired vaccine was stored and then administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. HCP said that 606 doses were given after expiration date. HCP said that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned. On 25-Nov-2021, vaccine was placed in refrigerator. Vaccine did not undergo any temperature excursion. No adverse events were reported.